Patients continuously monitored after surgery experienced significantly less time with dangerously low oxygen levels compared to those monitored using routine spot checks, a new study from Wake Forest ...
WINSTON-SALEM, N.C. — Patients continuously monitored after surgery experienced significantly less time with dangerously low oxygen levels compared to those monitored using routine spot checks, a new ...
Stocks are a mixed bag this afternoon, with the Dow Jones Industrial Average (DJI) up 85 points, the S&P 500 Index (SPX) quietly higher, and the Nasdaq Composite (IXIC) nursing a triple-digit deficit.
Dartmouth researchers have developed a cell phone-based tool that monitors tissue health by using a naturally occurring molecule to measure the oxygen level in cells. The tool could provide a simple ...
New York – U.S. stocks lost steam on Tuesday, giving up early gains to skid into negative territory as investors weighed fading hopes for an earlier-than-expected end to the U.S.-Israeli war on Iran ...
If superior color accuracy and clear visual effects are your requirement, this 16-inch 3K OLED offers you a lot of top spec for such a portable display. The UPerfect UColor O2 is a second extended ...
We performed simultaneous (radial) arterial and (mixed) venous blood gas lactate measurements in 1526 patients at a quaternary cardiac Intensive Care Unit (ICU; both surgical [n=1356, 86%] and ...
In his latest State of the Union address to Congress, US President Donald Trump spoke of Iran's 'sinister nuclear ambitions' — ANDREW CABALLERO-REYNOLDS US President Donald Trump appears to be leaning ...
Rochester, Minn.-based Mayo Clinic is collaborating with Profusa to investigate and commercialize clinical applications of the company’s oxygen monitoring technologies. The partnership will explore ...
A routine cardiac MRI scan may be comparable to right heart catheterization for determining the severity of heart failure, according to a study in JACC: Advances. Researchers in England developed a ...
(RTTNews) - Profusa, Inc. (PFSA), a commercial-stage digital health company developing tissue-integrated biosensors, announced it has entered into a know-how agreement with Mayo Clinic to advance ...